“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients With Primary Axillary Hyperhydrosis”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S40. Accessed April 13, 2025. https://skin.dermsquared.com/skin/article/view/268.